184 related articles for article (PubMed ID: 25287661)
41. Associations of circulating CXCR3
Han L; Yang X; Yu Y; Wan W; Lv L; Zou H
Mod Rheumatol; 2019 May; 29(3):461-469. PubMed ID: 29694256
[TBL] [Abstract][Full Text] [Related]
42. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.
Ma L; Zhao P; Jiang Z; Shan Y; Jiang Y
Clin Exp Immunol; 2013 Dec; 174(3):345-55. PubMed ID: 23968502
[TBL] [Abstract][Full Text] [Related]
43. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
44. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
45. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
[TBL] [Abstract][Full Text] [Related]
46. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.
von Spee-Mayer C; Siegert E; Abdirama D; Rose A; Klaus A; Alexander T; Enghard P; Sawitzki B; Hiepe F; Radbruch A; Burmester GR; Riemekasten G; Humrich JY
Ann Rheum Dis; 2016 Jul; 75(7):1407-15. PubMed ID: 26324847
[TBL] [Abstract][Full Text] [Related]
47. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
[TBL] [Abstract][Full Text] [Related]
48. Correlation of the levels of DNA-binding inhibitor Id3 and regulatory T cells with SLE disease severity.
Liu C; Yu S; Jin R; Long Y; Lu S; Song Y; Sun X; Sun XH; Zhang Y
J Autoimmun; 2020 Sep; 113():102498. PubMed ID: 32536579
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
50. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
51. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes.
Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P
Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616
[TBL] [Abstract][Full Text] [Related]
52. Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
Chen J; Ding L; Meng W; Yang J; Yan C; Xie J; Jing L; Li X; Fu Z
Med Sci Monit; 2015 Feb; 21():505-10. PubMed ID: 25683262
[TBL] [Abstract][Full Text] [Related]
53. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
[TBL] [Abstract][Full Text] [Related]
54. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
55. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
[TBL] [Abstract][Full Text] [Related]
56. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
[TBL] [Abstract][Full Text] [Related]
57. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
58. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
59. [The expression of CD73 in CD4+ regulatory T cells in patients with new-onset systemic lupus erythematosus].
Li DM; Li XP; Zhang JH; Hu SR; Xiao B; Chen W; Zeng XF
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):772-5. PubMed ID: 21092450
[TBL] [Abstract][Full Text] [Related]
60. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
